First Amendment to Non-Prosecution Agreement between Tenet HealthSystem Medical, Inc. and the United States Department of Justice

Term of the Agreement. Tenet Subsidiary’s and Tenet’s obligations under this Agreement shall have a term of 3 years and 9 months from the date on which the independent monitor is retained by Tenet, as described below (the “Term”). Tenet Subsidiary agrees, however, that in the event the Department determines, in its sole discretion, that Tenet Subsidiary or Tenet, or any of Tenet’s subsidiaries or affiliates has knowingly violated any provision of this Agreement, subject to Paragraph 12, below, an extension or extensions of the term of the Agreement may be imposed by the Department, in their sole discretion, for up to a total additional time period of three months, without prejudice to the Department’s right to proceed as provided in Paragraphs 13-14, below. Any extension of this Agreement extends all terms of the Agreement, including the terms of the monitorship in Attachment C, for an equivalent period. Conversely, in the event the Department finds, in its sole discretion, that there exists a change in circumstances sufficient to eliminate the need for a monitorship as described in Attachment C, or that other provisions of this Agreement have been satisfied, the monitorship or the Term of this Agreement may be terminated early.

2.    In all other respects, the Non-Prosecution Agreement shall remain in full force

and effect.

FOR THE DEPARTMENT OF JUSTICE:

AGREED AND CONSENTED TO:

Tenet HealthSystem Medical, Inc.*

_________________________

* Where Tenet is indicated in the Amendment to the Agreement and Agreement, Tenet Subsidiary is acting on behalf of Tenet

WHEREAS, on September 30, 2016, Tenet HealthSystem Medical, Inc. (“THSM”), a wholly-owned subsidiary of Tenet Healthcare Corporation (the “Company”) entered into a Non-Prosecution Agreement with the U.S. Department of Justice and the U.S. Attorney’s Office for the Northern District of Georgia (the “Department”);

WHEREAS, in November 2017, the Department provided notice to the Company’s outside counsel and its Board of Directors (the “Board”) of the Department’s determination that Tenet and THSM had breached the terms of the NPA by failing to promptly report to the Department certain reportable events as required by Paragraph 5.e. of the NPA;

WHEREAS, in April 2018, after engaging in dialogue and consideration of the nature, facts and circumstances surrounding the breach, as well as the Company’s actions and efforts to remediate the situation, the Department determined that a nine-month extension of the term of the NPA, including the monitorship described therein, is an appropriate remedy and proposed a form of Amendment to the Non-Prosecution Agreement (the “Amendment”) for the Board’s consideration; and

WHEREAS, the Board has considered the form of Amendment and, based upon the advice and recommendations of the Company’s external counsel and its management, the Board has determined to authorize THSM to enter into the Amendment for and on behalf of itself and the Company.

NOW THEREFORE, BE IT RESOLVED that each of (i) the Company’s Executive Chairman and Chief Executive Officer, its Senior Vice President and General Counsel or any Senior Vice President or any Vice President, and (ii) the Company’s external counsel from Latham & Watkins LLP, be, and each of them hereby is, authorized to execute the Amendment for and on behalf of THSM and the Company.

Anthony L. Shoemaker

Corporate Secretary